Petra Seibold

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Data from Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review
  2026 DOI: 10.1158/1055-9965.c.8542453
  +Save
• Supplementary Figure S1 from Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review
  2026 DOI: 10.1158/1055-9965.32709763
  +Save
• Supplementary Figure S2 from Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review
  2026 DOI: 10.1158/1055-9965.32709760
  +Save
• Supplementary Material S1 from Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review
  2026 DOI: 10.1158/1055-9965.32709757
  +Save
• Supplementary Material S2 from Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review
  2026 DOI: 10.1158/1055-9965.32709754
  +Save
• Supplementary Table S1 from Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review
  2026 DOI: 10.1158/1055-9965.32709751
  +Save
• Supplementary Table S2 from Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review
  2026 DOI: 10.1158/1055-9965.32709748
  +Save
• Supplementary Table S3 from Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review
  2026 DOI: 10.1158/1055-9965.32709745
  +Save
• Supplementary Table S4 from Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review
  2026 DOI: 10.1158/1055-9965.32709742
  +Save
• Clinical Validity of Circulating Tumor DNA as a Diagnostic Biomarker for Prostate Cancer: A Systematic Review
  Cancer Epidemiology, Biomarkers & Prevention 2026 DOI: 10.1158/1055-9965.EPI-25-1820
  +Save
• Sensitivity analysis of dose-response model parameters for the bladder in prostate cancer radiotherapy
  Physica Medica 2025 DOI: 10.1016/j.ejmp.2025.105178
  +Save
• Cost effectiveness analysis of prostate cancer screening strategies in Germany: A microsimulation study
  International Journal of Cancer 2025 DOI: 10.1002/ijc.35513
  +Save
• The healthy participant effect: insights and results from a population-based case–control study on breast cancer
  American Journal of Epidemiology 2025 DOI: 10.1093/aje/kwae155
  +Save
• Longitudinal changes of health-related quality of life over 10 years in breast cancer patients treated with radiotherapy following breast-conserving surgery
  Quality of Life Research 2023 DOI: 10.1007/s11136-023-03408-y
  +Save